Fish oil supplementation during pregnancy, anthropometrics, and metabolic health at age ten: A randomized clinical trial
CONCLUSIONS: In this randomized clinical trial, children of mothers receiving n-3 LCPUFA supplementation had increased BMI at age 10 y, increased risk of being overweight, and a tendency of increased fat percentage and higher metabolic syndrome score. These findings suggest potential adverse health effects from n-3 LCPUFA supplementation during pregnancy and need to be replicated in future independent studies. This trial was registered at clinicaltrials.gov as NCT00798226.PMID:38569788 | DOI:10.1016/j.ajcnut.2023.12.015
Source: The American Journal of Clinical Nutrition - Category: Nutrition Authors: Rebecca K Vinding Astrid Sevelsted David Horner Nilofar Vahman Lotte Lauritzen Casper P Hagen Bo Chawes Jakob Stokholm Klaus B ønnelykke Source Type: research
More News: Asthma | Children | Cholesterol | Clinical Trials | Fish | Fish Oil | Metabolic Syndrome | Nutrition | Obesity | Pregnancy | Study